Editor-in-Chief: V. Susan Carroll, MS, RN-BC, SCRN
ISSN: 0888-0395
Online ISSN: 1945-2810
Frequency: 6 issues per year
Impact Factor: .815
AANN Stroke Conference
From the Editor
Congratulations to our JNN Writing Awards winners - Esther Bay, PhD, ACNS-BC, won the Writing Award for her paper titled "Chronic Morbidities post-Traumatic Brain Injury: An Update for Advanced Practice. Malissa Mulkey, MSN, won the Novice Writing Award for her manuscript "Clinical Outcomes of Patient Mobility in a Neuroscience Intensive Care Unit." Both authors received their awards at the AANN Annual Educational Conference in Nashville. Be sure to read both articles! Once again, JNN is seeking manuscript reviewers with particular expertise in epilepsy, pediatrics, neuromuscular disorders, pharmacology and/or research methods. If interested, contact me or JNN's Editorial Assistant. Both email addresses are in the print journal or our website.
Featured Supplement

JNN December 2013 Supplement

This supplement was developed with the support of Genzyme, a Sanofi company.


Current Issue Highlights


American Association of Neuroscience Nurses Official Journal of
American Association of Neuroscience Nurses

To receive access to the online journal, association members must log-in through the AANN website in the members-only area. Please click below:

American Association of Neuroscience Nurses

In the News
News you can use .... Chris Borland, a 24-year old rookie tackle for the SF 49ers, has "retired" from pro football after one season. This is the latest event in the on-going NFL concussions issue. Although he had experienced just 2 concussions (both in middle or high school) he exits pro football to avoid potentially life-changing brain injury. He joins 3 other high profile retirements this off-season -- Patrick Willis, also a 49er, Jason Worilds, a Steelers' linebacker, and Jake Locker, the Titans' quarterback. Economists from MIT report that very few studies designed to improve the US health care system use random assignment as a research method. This is in stark contrast to American drug studies which use randomized design 86% of the time. Lack of randomization may mean that at the end of a study, little definitive evidence related to innovations actually exists. The US Supreme Court continues to evaluate the legality of 2010's Affordable Care Act subsidies. Although a decision may be months away, the ACA has meant that 16 million individuals have gained health insurance and that all racial and ethnic groups have seen gains in coverage.